1. Home
  2. RLYB vs KULR Comparison

RLYB vs KULR Comparison

Compare RLYB & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • KULR
  • Stock Information
  • Founded
  • RLYB 2018
  • KULR 2013
  • Country
  • RLYB United States
  • KULR United States
  • Employees
  • RLYB N/A
  • KULR N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • KULR Electrical Products
  • Sector
  • RLYB Health Care
  • KULR Technology
  • Exchange
  • RLYB Nasdaq
  • KULR Nasdaq
  • Market Cap
  • RLYB 24.1M
  • KULR 163.0M
  • IPO Year
  • RLYB 2021
  • KULR N/A
  • Fundamental
  • Price
  • RLYB $0.64
  • KULR $2.64
  • Analyst Decision
  • RLYB Hold
  • KULR Strong Buy
  • Analyst Count
  • RLYB 2
  • KULR 2
  • Target Price
  • RLYB N/A
  • KULR $40.00
  • AVG Volume (30 Days)
  • RLYB 264.7K
  • KULR 1.7M
  • Earning Date
  • RLYB 11-06-2025
  • KULR 11-18-2025
  • Dividend Yield
  • RLYB N/A
  • KULR N/A
  • EPS Growth
  • RLYB N/A
  • KULR N/A
  • EPS
  • RLYB N/A
  • KULR N/A
  • Revenue
  • RLYB $674,000.00
  • KULR $12,977,975.00
  • Revenue This Year
  • RLYB N/A
  • KULR $27.50
  • Revenue Next Year
  • RLYB N/A
  • KULR $164.50
  • P/E Ratio
  • RLYB N/A
  • KULR N/A
  • Revenue Growth
  • RLYB 12.71
  • KULR 35.81
  • 52 Week Low
  • RLYB $0.22
  • KULR $2.48
  • 52 Week High
  • RLYB $1.24
  • KULR $43.92
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 53.76
  • KULR 25.27
  • Support Level
  • RLYB $0.62
  • KULR $2.94
  • Resistance Level
  • RLYB $0.72
  • KULR $3.08
  • Average True Range (ATR)
  • RLYB 0.05
  • KULR 0.21
  • MACD
  • RLYB 0.00
  • KULR -0.07
  • Stochastic Oscillator
  • RLYB 37.50
  • KULR 2.67

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.

Share on Social Networks: